| (−) ML141 | (+) ML141 (d–2/14) | (+) ML141 (d14/28) | |||
---|---|---|---|---|---|---|
D0 | D7 | D14 | D28 | D28 | D28 | |
Differentiation of hADSCs derived from young subjects | ||||||
 HLA-DR | 2.03 ± 0.53 | 0.02 ± 0.11 | 2.55 ± 0.11 | 0.51 ± 0.92 |  |  |
 CD14+ | 0.12 ± 0.40 | 0.14 ± 0.24 | 0.15 ± 0.38 | 0.08 ± 0.32 |  | |
 CD34+ | 1.17 ± 1.88 | 6.03 ± 0.52 | 3.20 ± 0.68 | 1.12 ± 0.44 |  | |
 CD45+ | 0.06 ± 0.43 | 0.07 ± 0.98 | 0.05 ± 0.12 | 0.26 ± 0.75 |  | |
 CD73+ | 88.61 ± 3.92 | 72.30 ± 10.39* | 37.33 ± 2.05** | 19.14 ± 1.62*** | 16.44 ± 5.23** | 21.36 ± 3.98** |
 CD90+ | 90.96 ± 6.80 | 74.43 ± 3.76* | 36.41 ± 2.16*** | 17.09 ± 0.84*** | 10.38 ± 3.41*** | 7.33 ± 4.26*** |
 CD105+ | 91.09 ± 7.68 | 53.07 ± 1.24* | 40.25 ± 6.43*** | 20.72 ± 3.51*** | 14.25 ± 4.12*** | 15.13 ± 5.22*** |
Differentiation of hADSCs derived from aged subjects | ||||||
 HLA-DR | 1.44 ± 0.37 | 0.33 ± 0.10 | 1.50 ± 0.42 | 1.61 ± 0.86 |  |  |
 CD14+ | 0.11 ± 0.10 | 0.91 ± 0.82 | 0.11 ± 0.41 | 0.42 ± 0.13 |  | |
 CD34+ | 1.43 ± 0.24 | 1.80 ± 0.39 | 1.51 ± 0.80 | 0.98 ± 1.10 |  | |
 CD45+ | 0.02 ± 0.23 | 0.08 ± 0.34 | 0.03 ± 0.21 | 0.12 ± 0.33 |  | |
 CD73+ | 94.68 ± 3.58 | 85.07 ± 1.04 | 80.96 ± 4.96*§§ | 70.46 ± 2.29*§§ | 35.57 ± 0.71*# | 29.43 ± 3.16*# |
 CD90+ | 91.41 ± 6.80 | 80.23 ± 3.76 | 75.95 ± 2.11*§§ | 70.01 ± 4.08*§§ | 31.43 ± 1.60*# | 35.95 ± 1.42*# |
 CD105+ | 92.88 ± 3.09 | 71.40 ± 2.36*§ | 73.03 ± 2.30*§§ | 64.92 ± 3.15*§§ | 34.63 ± 3.09*# | 45.57 ± 2.81*# |